From: Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients
Subgroup | Equal | Expected | Reversed | Extreme EVT | Single subgroup | |||||
---|---|---|---|---|---|---|---|---|---|---|
 | PMM | PEVT | PMM | PEVT | PMM | PEVT | PMM | PEVT | PMM | PEVT |
Large Core Only | 0.1 | 0.1 | 0.1 | 0.25 | 0.25 | 0.1 | 0.1 | 0.30 | 0.25 | 0.45 |
Mild Deficit Only | 0.7 | 0.7 | 0.7 | 0.84 | 0.84 | 0.7 | 0.7 | 0.89 | 0.84 | 0.84 |
Distal Occlusion Only | 0.35 | 0.35 | 0.35 | 0.55 | 0.55 | 0.35 | 0.35 | 0.60 | 0.55 | 0.55 |
Distal Occlusion + Large core | 0.25 | 0.25 | 0.25 | 0.45 | 0.45 | 0.25 | 0.25 | 0.50 | 0.45 | 0.45 |
Distal Occlusion + Mild Deficit | 0.75 | 0.75 | 0.75 | 0.85 | 0.85 | 0.75 | 0.75 | 0.90 | 0.85 | 0.85 |